Chimerix to Present at Upcoming Investor Conferences
November 09 2016 - 8:00AM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing
novel antivirals to address unmet medical needs, today announced
that M. Michelle Berrey, M.D., M.P.H, President and Chief Executive
Officer of Chimerix, will present a corporate overview at the
following upcoming conferences:
- Stifel 2016 Healthcare Conference at 1:30 p.m.
ET on Tuesday, November 15, 2016 at the Lotte New York Palace Hotel
in New York
- 28th Annual Piper Jaffray Healthcare
Conference at 11:30 a.m. ET on Wednesday, November 30,
2016 at the Lotte New York Palace Hotel in New York
A live audio webcast of each presentation will be available on
the Investor Relations section of Chimerix’s website at
www.chimerix.com, where it will be archived for approximately 90
days.
About Chimerix
Chimerix is a biopharmaceutical company dedicated to
discovering, developing and commercializing novel antivirals in
areas of high unmet medical need. Chimerix's proprietary lipid
conjugate technology has produced brincidofovir (BCV, CMX001);
CMX157, which was licensed to ContraVir Pharmaceuticals; and
earlier-stage compounds. Chimerix is also advancing a
clinical candidate for norovirus infection, CMX521. For further
information, please
visit Chimerix's website www.chimerix.com.
CONTACT:
Investor Relations:
ir@chimerix.com
or
Will O’Connor
Stern Investor Relations
Will@sternir.com
212-362-1200
Media:
Becky Vonsiatsky
W2O Group
bvonsiatsky@w2ogroup.com
413-478-2003
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2024 to May 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From May 2023 to May 2024